The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(4-fluorophenyl)-5-methylthiazol-2-ylamino)-N-(2-oxopropyl)benzamide ID: ALA4879293
PubChem CID: 164627333
Max Phase: Preclinical
Molecular Formula: C20H18FN3O2S
Molecular Weight: 383.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)CNC(=O)c1cccc(Nc2nc(-c3ccc(F)cc3)c(C)s2)c1
Standard InChI: InChI=1S/C20H18FN3O2S/c1-12(25)11-22-19(26)15-4-3-5-17(10-15)23-20-24-18(13(2)27-20)14-6-8-16(21)9-7-14/h3-10H,11H2,1-2H3,(H,22,26)(H,23,24)
Standard InChI Key: PBWJKXJONKLGDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
12.3926 -11.9731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3915 -12.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0995 -13.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8092 -12.7921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8064 -11.9695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0978 -11.5642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5176 -13.1996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2246 -12.7899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9699 -13.1158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5157 -12.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1060 -11.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3070 -11.9718 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.3235 -12.5899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6563 -13.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4683 -13.4219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9485 -12.7596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6108 -12.0108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7997 -11.9300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4372 -11.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7615 -12.8427 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.0953 -10.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8018 -10.3363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3864 -10.3405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3840 -9.5233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6750 -9.1169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6726 -8.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9685 -9.5276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
10 13 1 0
11 19 1 0
16 20 1 0
6 21 1 0
21 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.45Molecular Weight (Monoisotopic): 383.1104AlogP: 4.32#Rotatable Bonds: 6Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.34CX Basic pKa: 2.83CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.93
References 1. Zhang Y, Liu J, Wu X, Yang S, Li Y, Liu S, Zhu S, Cao X, Xie Z, Lei X, Huang H, Peng J.. (2021) Anti-chronic myeloid leukemia activity and quantitative structure-activity relationship of novel thiazole aminobenzamide derivatives., 44 [PMID:34015503 ] [10.1016/j.bmcl.2021.128116 ]